Correlation
The correlation between IART and HOLX is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
IART vs. HOLX
Compare and contrast key facts about Integra LifeSciences Holdings Corporation (IART) and Hologic, Inc. (HOLX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IART or HOLX.
Performance
IART vs. HOLX - Performance Comparison
Loading data...
Key characteristics
IART:
-1.00
HOLX:
-0.51
IART:
-1.49
HOLX:
-0.64
IART:
0.80
HOLX:
0.92
IART:
-0.67
HOLX:
-0.38
IART:
-1.66
HOLX:
-0.90
IART:
33.90%
HOLX:
16.97%
IART:
59.06%
HOLX:
28.37%
IART:
-87.75%
HOLX:
-93.75%
IART:
-83.48%
HOLX:
-29.09%
Fundamentals
IART:
$986.17M
HOLX:
$14.02B
IART:
-$0.38
HOLX:
$2.35
IART:
0.67
HOLX:
1.39
IART:
0.61
HOLX:
3.48
IART:
0.65
HOLX:
3.00
IART:
$1.62B
HOLX:
$4.03B
IART:
$1.06B
HOLX:
$2.08B
IART:
$150.97M
HOLX:
$1.02B
Returns By Period
In the year-to-date period, IART achieves a -44.18% return, which is significantly lower than HOLX's -13.76% return. Over the past 10 years, IART has underperformed HOLX with an annualized return of -6.28%, while HOLX has yielded a comparatively higher 5.55% annualized return.
IART
-44.18%
-22.99%
-48.49%
-59.03%
-41.31%
-24.65%
-6.28%
HOLX
-13.76%
8.54%
-21.80%
-15.74%
-6.17%
3.24%
5.55%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IART vs. HOLX — Risk-Adjusted Performance Rank
IART
HOLX
IART vs. HOLX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Integra LifeSciences Holdings Corporation (IART) and Hologic, Inc. (HOLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
IART vs. HOLX - Dividend Comparison
Neither IART nor HOLX has paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
IART Integra LifeSciences Holdings Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.80% |
HOLX Hologic, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
IART vs. HOLX - Drawdown Comparison
The maximum IART drawdown since its inception was -87.75%, smaller than the maximum HOLX drawdown of -93.75%. Use the drawdown chart below to compare losses from any high point for IART and HOLX.
Loading data...
Volatility
IART vs. HOLX - Volatility Comparison
Integra LifeSciences Holdings Corporation (IART) has a higher volatility of 29.56% compared to Hologic, Inc. (HOLX) at 17.70%. This indicates that IART's price experiences larger fluctuations and is considered to be riskier than HOLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
IART vs. HOLX - Financials Comparison
This section allows you to compare key financial metrics between Integra LifeSciences Holdings Corporation and Hologic, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IART vs. HOLX - Profitability Comparison
IART - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Integra LifeSciences Holdings Corporation reported a gross profit of 382.65M and revenue of 382.65M. Therefore, the gross margin over that period was 100.0%.
HOLX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Hologic, Inc. reported a gross profit of 382.00M and revenue of 1.01B. Therefore, the gross margin over that period was 38.0%.
IART - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Integra LifeSciences Holdings Corporation reported an operating income of -15.50M and revenue of 382.65M, resulting in an operating margin of -4.1%.
HOLX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Hologic, Inc. reported an operating income of -7.00M and revenue of 1.01B, resulting in an operating margin of -0.7%.
IART - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Integra LifeSciences Holdings Corporation reported a net income of -25.29M and revenue of 382.65M, resulting in a net margin of -6.6%.
HOLX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Hologic, Inc. reported a net income of -17.40M and revenue of 1.01B, resulting in a net margin of -1.7%.